Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Martin Cloutier

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Drug Discovery Today|August 5, 2008
Needed: system dynamics for the drug discovery processSuzanne Sirois, L Martin Cloutier
Drug Discovery Today|June 14, 2008
Bayesian versus Frequentist statistical modeling: a debate for hit selection from HTS campaignsL Martin Cloutier, Suzanne Sirois
Journal of Medical Economics|March 25, 2015
Costing bias in economic evaluationsJulie Frappier, Gabriel Tremblay, Mark Charny, et al.
Journal of Medical Internet Research|September 16, 2025
Understanding Economic Decision-Making in Digital Therapeutics Development: Qualitative ApproachYoann Sapanel, L Martin Cloutier, Alec Morton, et al.
Trends in Biotechnology|July 20, 2002
Needed: models of biotechnology intellectual propertyE Richard Gold, David Castle, L Martin Cloutier, et al.
NPJ Digital Medicine|April 9, 2025
A group concept mapping study of stakeholder perspectives on digital therapeutics economic value driversYoann Sapanel, L Martin Cloutier, Gabriel Tremblay, et al.
Public Affairs Quarterly|April 9, 2005
The unexamined assumptions of intellectual property: adopting an evaluative approach to patenting biotechnological innovationE Richard Gold, Wen Adams, David Castle, et al.
Journal of Medical Internet Research|August 1, 2023
Economic Evaluation Associated With Clinical-Grade Mobile App-Based Digital Therapeutic Interventions: Systematic ReviewYoann Sapanel, Xavier Tadeo, Connor T A Brenna, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Drug Discovery Today|August 5, 2008
Needed: system dynamics for the drug discovery processSuzanne Sirois, L Martin Cloutier
Drug Discovery Today|June 14, 2008
Bayesian versus Frequentist statistical modeling: a debate for hit selection from HTS campaignsL Martin Cloutier, Suzanne Sirois
Journal of Medical Economics|March 25, 2015
Costing bias in economic evaluationsJulie Frappier, Gabriel Tremblay, Mark Charny, et al.
Journal of Medical Internet Research|September 16, 2025
Understanding Economic Decision-Making in Digital Therapeutics Development: Qualitative ApproachYoann Sapanel, L Martin Cloutier, Alec Morton, et al.
Trends in Biotechnology|July 20, 2002
Needed: models of biotechnology intellectual propertyE Richard Gold, David Castle, L Martin Cloutier, et al.
NPJ Digital Medicine|April 9, 2025
A group concept mapping study of stakeholder perspectives on digital therapeutics economic value driversYoann Sapanel, L Martin Cloutier, Gabriel Tremblay, et al.
Public Affairs Quarterly|April 9, 2005
The unexamined assumptions of intellectual property: adopting an evaluative approach to patenting biotechnological innovationE Richard Gold, Wen Adams, David Castle, et al.
Journal of Medical Internet Research|August 1, 2023
Economic Evaluation Associated With Clinical-Grade Mobile App-Based Digital Therapeutic Interventions: Systematic ReviewYoann Sapanel, Xavier Tadeo, Connor T A Brenna, et al.
Pageof 1